title: Treatment of moderate or severe arterial hypertension with losartan.
abstract: Losartan is the first drug of a new class antihypertensive drags--Angiotensin II receptors antagonists. According to the data in the literature the drug shows a very good efficiency and tolerability. Fifteen patients at the average age of 48.9 are the object of this study. Our study establishes considerable lowering of the systolic BP with 15.9% and of the diastolic BP with 20.3%. No considerable effects on the hematopoiesis, the carbohydrate and the lipid metabolism, and the renal function were observed during treatment with Cozaar.
authors: Department of Cardiology, Medical University, Sofia, Bulgaria.
authors: A
authors: A
authors: Dimitrova
authors: M
authors: M
authors: Todorova
authors: K
authors: K
authors: Bianov
authors: N
authors: N
authors: Halachev
authors: S
authors: S
authors: Dineva
authors: A
authors: A
authors: Elenkova
mesh_terms: D000328:Adult; D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D019808:Losartan / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged
chemical_list: D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D019808:Losartan